Ren et al., 2015 - Google Patents
Detection of miRNA as non-invasive biomarkers of colorectal cancerRen et al., 2015
View HTML- Document ID
- 4606189817205445192
- Author
- Ren A
- Dong Y
- Tsoi H
- Yu J
- Publication year
- Publication venue
- International journal of molecular sciences
External Links
Snippet
Colorectal Cancer (CRC) is one of the deadliest cancers—ranking as the fourth most common cause of cancer-related deaths in the world. It is such a deadly disease because it is largely asymptomatic until the latter stages—oftentimes when the cancer has …
- 229920001239 microRNA 0 title abstract description 147
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6802—General aspects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ren et al. | Detection of miRNA as non-invasive biomarkers of colorectal cancer | |
James et al. | MicroRNA biomarkers in IBD—differential diagnosis and prediction of colitis-associated cancer | |
Inamura et al. | MicroRNA in lung cancer: novel biomarkers and potential tools for treatment | |
Rapado-González et al. | Circulating microRNAs as promising biomarkers in colorectal cancer | |
Anwar et al. | MicroRNAs: emerging novel clinical biomarkers for hepatocellular carcinomas | |
Masuda et al. | MicroRNAs as biomarkers in colorectal cancer | |
Pfeffer et al. | Detection of exosomal miRNAs in the plasma of melanoma patients | |
Yu et al. | Circulating microRNAs: potential biomarkers for cancer | |
Wang et al. | Tumor-associated circulating microRNAs as biomarkers of cancer | |
Huang et al. | Extracellular microRNAs in urologic malignancies: chances and challenges | |
Hibner et al. | Relevance of microRNAs as potential diagnostic and prognostic markers in colorectal cancer | |
Fortunato et al. | Assessment of circulating microRNAs in plasma of lung cancer patients | |
Siskova et al. | Colorectal adenomas—genetics and searching for new molecular screening biomarkers | |
Zhu et al. | Comprehensive characterization of serum microRNA profile in response to the emerging avian influenza A (H7N9) virus infection in humans | |
Zhang et al. | Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas | |
Pesta et al. | Plasma microRNA levels combined with CEA and CA19-9 in the follow-up of colorectal cancer patients | |
Peng et al. | Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer | |
Ludwig et al. | Combining miRNA and mRNA expression profiles in Wilms tumor subtypes | |
Nassar et al. | Circulating miRNA as biomarkers for colorectal cancer diagnosis and liver metastasis | |
Alves dos Santos et al. | Circulating exosomal miRNAs as biomarkers for the diagnosis and prognosis of colorectal cancer | |
Yu et al. | Circulating microRNA biomarkers for lung cancer detection in East Asian populations | |
Drobna et al. | Identification of endogenous control miRNAs for RT-qPCR in T-cell acute lymphoblastic leukemia | |
Tong et al. | Circulating microRNAs in young patients with acute coronary syndrome | |
El-Gewely et al. | Differentially expressed microRNAs in meningiomas grades I and II suggest shared biomarkers with malignant tumors | |
Cinque et al. | Circulating RNA in kidney cancer: What we know and what we still suppose |